Mineralys Therapeutics, Inc.
USD25.06
-3.79 (-13.14%)
CEO
Jon Congleton
IPO Date
2023-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$26.48
Prev. Close
$28.85
Day Low
$23.64
Day High
$26.78
52W Low
$12.59
52W High
$47.65
Market Cap
$1.66B
Volume
8.18M
| 417 |
| $27.55 |
| 19 May 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Disposed | 417 | $15.44 |
| 13 May 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 2,171 | $16.00 |
| 13 May 2026 | Rodman David Malcom | Chief Medical Officer | S-Sale | Disposed | 2,171 | $29.71 |
| 13 May 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 6,348 | $1.08 |
| 13 May 2026 | Rodman David Malcom | Chief Medical Officer | S-Sale | Disposed | 6,348 | $29.36 |
| 13 May 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 3,541 | $10.20 |
| 13 May 2026 | Rodman David Malcom | Chief Medical Officer | M-Exempt | Acquired | 4,166 | $14.25 |
| 13 May 2026 | Rodman David Malcom | Chief Medical Officer | S-Sale | Disposed | 14,056 | $28.58 |